Sutimlimab

Tax included
Sutimlimab, a first-in-class complement protein component 1, s subcomponent (C1s) inhibitor, can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase.
MedChemExpress 
HY-P99050

Data sheet

Size
Multiple sizes
Reactivity
Complement System
Application
COVID-19-immunoregulation
CAS
2049079-64-1